Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
CME Group ( (CME) ) has shared an announcement.
On February 2, 2026, CME Group Inc. notified its clients of pricing changes via Special Executive Report 9676 and made the notice available on its website, signaling an adjustment to the cost structure associated with its services. The company also clarified that this information, furnished under Item 7.01 of a current report, is not deemed filed for purposes of the Securities Exchange Act of 1934 and will not be incorporated into securities law filings unless explicitly referenced, limiting its legal and regulatory implications for investors and other stakeholders.
The most recent analyst rating on (CME) stock is a Buy with a $305.00 price target. To see the full list of analyst forecasts on CME Group stock, see the CME Stock Forecast page.
Spark’s Take on CME Stock
According to Spark, TipRanks’ AI Analyst, CME is a Outperform.
CME Group’s strong financial performance and strategic growth in market data and crypto trading are significant strengths. However, high valuation and potential overbought technical indicators pose risks. The earnings call revealed both resilience and challenges, with cost discipline and strategic focus providing a balanced outlook.
To see Spark’s full report on CME stock, click here.
More about CME Group
CME Group Inc. operates global derivatives exchanges, offering futures and options across asset classes such as interest rates, equities, foreign exchange, energy, agricultural commodities and metals, and serves a broad base of institutional and commercial market participants seeking risk management and price discovery.
Average Trading Volume: 1,903,859
Technical Sentiment Signal: Buy
Current Market Cap: $104.2B
See more data about CME stock on TipRanks’ Stock Analysis page.